Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$258K Buy
1,143
+1
+0.1% +$242 0.05% 208
2022
Q2
$278K Sell
1,142
-25
-2% -$6.13K 0.04% 229
2022
Q1
$282K Buy
1,167
+58
+5% +$13.3K 0.04% 255
2021
Q4
$250K Sell
1,109
-1,092
-50% -$230K 0.03% 263
2021
Q3
$468K Buy
2,201
+137
+7% +$31.5K 0.05% 246
2021
Q2
$503K Buy
2,064
+122
+6% +$30K 0.06% 218
2021
Q1
$483K Buy
1,942
+244
+14% +$58.2K 0.07% 198
2020
Q4
$390K Buy
1,698
+310
+22% +$71.5K 0.06% 193
2020
Q3
$353K Buy
1,388
+124
+10% +$30.7K 0.07% 171
2020
Q2
$298K Sell
1,264
-219
-15% -$50K 0.06% 179
2020
Q1
$301K Buy
1,483
+290
+24% +$63.3K 0.07% 165
2019
Q4
$288K Buy
1,193
+68
+6% +$15K 0.05% 199
2019
Q3
$217K Buy
+1,125
New +$216K 0.05% 205
2019
Q2
Sell
-1,298
Closed -$247K 256
2019
Q1
$247K Sell
1,298
-8
-0.6% -$1.53K 0.06% 179
2018
Q4
$254K Buy
+1,306
New +$255K 0.07% 174

Other funds holding AMGN

Kore Private Wealth's AMGN Position: Q3 2022 in Review

Kore Private Wealth increased its Amgen (AMGN) stake by 0.09% in Q3 2022, buying an estimated $242 and bringing the position to 1,143 shares worth $258K. The position accounts for 0.05% of the portfolio, ranked #208.

Kore Private Wealth first reported a position in AMGN in Q4 2018 and has held it in 15 quarters since. The position peaked at $503K in Q2 2021. 2,323 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

  • Kore Private Wealth held 1,143 shares of Amgen worth $258K as of Q3 2022.
  • Kore Private Wealth bought 1 Amgen share in Q3 2022, an estimated $242.
  • Amgen made up 0.05% of Kore Private Wealth's portfolio in Q3 2022, its #208 holding.
  • Kore Private Wealth first reported a position in Amgen in Q4 2018 and has held it in 15 quarters since.
  • Kore Private Wealth's Amgen position peaked at $503K in Q2 2021.
  • 2,323 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Kore Private Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.